(Q48703653)

14 February 2018

title

Resistance of experientially-induced changes in murine plus-maze behaviour to altered retest conditions. (English)

1 reference

14 February 2018

author name string

Rodgers RJ

1

1 reference

14 February 2018

Johnson NJ

2

1 reference

14 February 2018

Carr J

3

1 reference

14 February 2018

Hodgson TP

4

1 reference

14 February 2018

language of work or name

English

0 references

publication date

1 June 1997

1 reference

14 February 2018

Behavioural Brain Research

published in

1 reference

14 February 2018

volume

86

1 reference

14 February 2018

page(s)

71-77

1 reference

14 February 2018

issue

1

1 reference

14 February 2018

Lasting effects on rodent anxiety of a single exposure to a cat.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2896%2902248-6

7 January 2021

Effects of early protein malnutrition and repeated testing upon locomotor and exploratory behaviors in the elevated plus-maze

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2896%2902248-6

7 January 2021

Spatial learning and memory, maze running strategies and cholinergic mechanisms in two inbred strains of mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2896%2902248-6

7 January 2021

An ethological analysis of the effects of chlordiazepoxide and bretazenil (Ro 16-6028) in the murine elevated plus-maze

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2896%2902248-6

7 January 2021

Radial-maze performance and structural variation of the hippocampus in mice: a correlation with mossy fibre distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2896%2902248-6

7 January 2021

Behavioral responses to novelty and structural variation of the hippocampus in mice. II. Multivariate genetic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2896%2902248-6

7 January 2021

Ethopharmacological analysis of rat behavior on the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2896%2902248-6

7 January 2021

Effect of various training procedures on performance in an elevated plus-maze: possible relation with brain regional levels of benzodiazepine-like molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2896%2902248-6

7 January 2021

GABAergic influences on plus-maze behaviour in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2896%2902248-6

7 January 2021

One-trial tolerance to the effects of chlordiazepoxide on the elevated plus maze may be due to locomotor habituation, not repeated drug exposure.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2896%2902248-6

7 January 2021

A new one-trial test for neurobiological studies of memory in rats. III. Spatial vs. non-spatial working memory

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2896%2902248-6

7 January 2021

The influence of open arm ledges and maze experience in the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2896%2902248-6

7 January 2021

One-trial tolerance to the anxiolytic effects of chlordiazepoxide in the plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2896%2902248-6

7 January 2021

Characterisation of the phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2896%2902248-6

7 January 2021

"One-trial tolerance" to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2896%2902248-6

7 January 2021

Raised corticosterone in the rat after exposure to the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2896%2902248-6

7 January 2021

Trial 2 in the elevated plus-maze: a different form of fear?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2896%2902248-6

7 January 2021

Some critical determinants of the behaviour of rats in the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2896%2902248-6

7 January 2021

A review of the validity and variability of the elevated plus-maze as an animal model of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2896%2902248-6

7 January 2021

Utility of an elevated plus-maze for the evaluation of memory in mice: effects of nootropics, scopolamine and electroconvulsive shock

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2896%2902248-6

7 January 2021

Simplifying environmental cues in a Morris-type water maze improves place learning in old NMRI mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2896%2902248-6

7 January 2021

Antinociceptive effects of elevated plus-maze exposure: influence of opiate receptor manipulations.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2896%2902248-6

7 January 2021

The use of a plus-maze to measure anxiety in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2896%2902248-6

7 January 2021

Ethologically-based animal models of anxiety disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2896%2902248-6

7 January 2021

Spatial localization does not require the presence of local cues

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2896%2902248-6

7 January 2021

Developments of a water-maze procedure for studying spatial learning in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2896%2902248-6

7 January 2021

Spatial memory and radial arm maze performance of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2896%2902248-6

7 January 2021

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2896%2902248-6

7 January 2021

Ethopharmacological analysis of the effects of putative 'anxiogenic' agents in the mouse elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2896%2902248-6

7 January 2021

Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2896%2902248-6

7 January 2021

Plus-maze retest profile in mice: importance of initial stages of trail 1 and response to post-trail cholinergic receptor blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2896%2902248-6

7 January 2021

Effects of diazepam on behavioural and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2896%2902248-6

7 January 2021

Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2896%2902248-6

7 January 2021

Behavioural strategies, sensorial processes and hippocampal mossy fibre distribution in radial maze performance in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2896%2902248-6

7 January 2021

A study of behavioral and sensorial bases of radial maze learning in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2896%2902248-6

7 January 2021

Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2896%2902248-6

7 January 2021

Anxiogenic stimuli in the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2896%2902248-6

7 January 2021

Effects of scopolamine on radial maze performance in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2896%2902248-6

7 January 2021

10.1016/S0166-4328(96)02248-6

Identifiers

DOI

1 reference

14 February 2018

PubMed ID

9105584

1 reference

14 February 2018